The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Angiotensin II Receptor Blockers Market Research Report 2024
Synopsis
Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.
The global Angiotensin II Receptor Blockers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blockers.
Report Scope
The Angiotensin II Receptor Blockers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin II Receptor Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin II Receptor Blockers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Segment by Type
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Segment by Application
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiotensin II Receptor Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiotensin II Receptor Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.
The global Angiotensin II Receptor Blockers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blockers.
Report Scope
The Angiotensin II Receptor Blockers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin II Receptor Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin II Receptor Blockers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
AstraZeneca
Novartis
Teva
Bayer
GlaxoSmithKline
Sun Pharmaceutical
Mylan
Segment by Type
Azilsartan
Candesartan
Eprosartan
Irbesartan
Losartan
Olmesartan
Telmisartan
Valsartan
Segment by Application
Chronic Kidney Diseases
Heart Failure
Kidney Failure in Diabetes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiotensin II Receptor Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiotensin II Receptor Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Angiotensin II Receptor Blockers Market Overview
1.1 Product Overview and Scope of Angiotensin II Receptor Blockers
1.2 Angiotensin II Receptor Blockers Segment by Type
1.2.1 Global Angiotensin II Receptor Blockers Market Value Comparison by Type (2024-2030)
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Angiotensin II Receptor Blockers Segment by Application
1.3.1 Global Angiotensin II Receptor Blockers Market Value by Application: (2024-2030)
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Global Angiotensin II Receptor Blockers Market Size Estimates and Forecasts
1.4.1 Global Angiotensin II Receptor Blockers Revenue 2019-2030
1.4.2 Global Angiotensin II Receptor Blockers Sales 2019-2030
1.4.3 Global Angiotensin II Receptor Blockers Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Angiotensin II Receptor Blockers Market Competition by Manufacturers
2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2019-2024)
2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Angiotensin II Receptor Blockers Average Price by Manufacturers (2019-2024)
2.4 Global Angiotensin II Receptor Blockers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiotensin II Receptor Blockers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiotensin II Receptor Blockers, Product Type & Application
2.7 Angiotensin II Receptor Blockers Market Competitive Situation and Trends
2.7.1 Angiotensin II Receptor Blockers Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue
2.7.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Angiotensin II Receptor Blockers Retrospective Market Scenario by Region
3.1 Global Angiotensin II Receptor Blockers Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Angiotensin II Receptor Blockers Global Angiotensin II Receptor Blockers Sales by Region: 2019-2030
3.2.1 Global Angiotensin II Receptor Blockers Sales by Region: 2019-2024
3.2.2 Global Angiotensin II Receptor Blockers Sales by Region: 2025-2030
3.3 Global Angiotensin II Receptor Blockers Global Angiotensin II Receptor Blockers Revenue by Region: 2019-2030
3.3.1 Global Angiotensin II Receptor Blockers Revenue by Region: 2019-2024
3.3.2 Global Angiotensin II Receptor Blockers Revenue by Region: 2025-2030
3.4 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.4.1 North America Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Angiotensin II Receptor Blockers Sales by Country (2019-2030)
3.4.3 North America Angiotensin II Receptor Blockers Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.5.1 Europe Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Angiotensin II Receptor Blockers Sales by Country (2019-2030)
3.5.3 Europe Angiotensin II Receptor Blockers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.6.1 Asia Pacific Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Angiotensin II Receptor Blockers Sales by Country (2019-2030)
3.6.3 Asia Pacific Angiotensin II Receptor Blockers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.7.1 Latin America Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Angiotensin II Receptor Blockers Sales by Country (2019-2030)
3.7.3 Latin America Angiotensin II Receptor Blockers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Angiotensin II Receptor Blockers Sales by Type (2019-2030)
4.1.1 Global Angiotensin II Receptor Blockers Sales by Type (2019-2024)
4.1.2 Global Angiotensin II Receptor Blockers Sales by Type (2025-2030)
4.1.3 Global Angiotensin II Receptor Blockers Sales Market Share by Type (2019-2030)
4.2 Global Angiotensin II Receptor Blockers Revenue by Type (2019-2030)
4.2.1 Global Angiotensin II Receptor Blockers Revenue by Type (2019-2024)
4.2.2 Global Angiotensin II Receptor Blockers Revenue by Type (2025-2030)
4.2.3 Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2019-2030)
4.3 Global Angiotensin II Receptor Blockers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Angiotensin II Receptor Blockers Sales by Application (2019-2030)
5.1.1 Global Angiotensin II Receptor Blockers Sales by Application (2019-2024)
5.1.2 Global Angiotensin II Receptor Blockers Sales by Application (2025-2030)
5.1.3 Global Angiotensin II Receptor Blockers Sales Market Share by Application (2019-2030)
5.2 Global Angiotensin II Receptor Blockers Revenue by Application (2019-2030)
5.2.1 Global Angiotensin II Receptor Blockers Revenue by Application (2019-2024)
5.2.2 Global Angiotensin II Receptor Blockers Revenue by Application (2025-2030)
5.2.3 Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2019-2030)
5.3 Global Angiotensin II Receptor Blockers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co. Angiotensin II Receptor Blockers Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Angiotensin II Receptor Blockers Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Angiotensin II Receptor Blockers Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Angiotensin II Receptor Blockers Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Angiotensin II Receptor Blockers Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Angiotensin II Receptor Blockers Product Portfolio
6.8.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiotensin II Receptor Blockers Industry Chain Analysis
7.2 Angiotensin II Receptor Blockers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiotensin II Receptor Blockers Production Mode & Process
7.4 Angiotensin II Receptor Blockers Sales and Marketing
7.4.1 Angiotensin II Receptor Blockers Sales Channels
7.4.2 Angiotensin II Receptor Blockers Distributors
7.5 Angiotensin II Receptor Blockers Customers
8 Angiotensin II Receptor Blockers Market Dynamics
8.1 Angiotensin II Receptor Blockers Industry Trends
8.2 Angiotensin II Receptor Blockers Market Drivers
8.3 Angiotensin II Receptor Blockers Market Challenges
8.4 Angiotensin II Receptor Blockers Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
